Methotrexate Pfizer (Methotrexate)

Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for converting folate into its active form. This disruption limits the synthesis of DNA, RNA and proteins, particularly in rapidly dividing cells. The resulting antiproliferative effect, combined with modulation of immune signaling, provides both anti‑inflammatory and anticancer activity.

The specific dose of Methotrexate Pfizer is determined individually by a qualified prescriber based on the patient’s condition, weight, renal and hepatic function, and treatment goals. Healthcare professionals calculate the appropriate regimen and provide detailed instructions for safe administration.

Methotrexate is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of birth defects and fetal loss. It is also not recommended for breastfeeding mothers because the drug can be excreted in breast milk and may harm the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Methotrexate is often considered a first‑line conventional DMARD because of its oral route, extensive clinical experience and cost‑effectiveness. Compared with biologic agents, it has a broader safety monitoring profile but may be less rapid in controlling severe disease. In many treatment algorithms, methotrexate is used alone or in combination with biologics to enhance efficacy.

Methotrexate Pfizer should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in extreme heat or humidity, and keep it out of reach of children.

Methotrexate Pfizer is supplied as an oral formulation. It is taken by mouth with a full glass of water, usually on a weekly schedule as directed by the prescriber. Patients are often advised to take the medication on an empty stomach and to follow any specific timing recommendations related to folic acid supplementation.

The most serious adverse effects include severe liver toxicity that can progress to fibrosis or cirrhosis, bone marrow suppression leading to pancytopenia, and pulmonary toxicity such as interstitial pneumonitis. Prompt monitoring of liver enzymes, blood counts and respiratory symptoms is essential to detect these risks early.

Methotrexate Pfizer should be avoided in pregnant or breastfeeding individuals, patients with severe hepatic impairment, uncontrolled renal disease, or known hypersensitivity to methotrexate. It is also contraindicated in patients with active infections that could be worsened by immunosuppression.